Author:
Mohareb Amir M.,Brown Bryan,Ikuta Kevin S.,Hyle Emily P.,Annamalai Aniyizhai
Abstract
Abstract
Background
Refugees are frequently not immune to vaccine-preventable infections. Adherence to consensus guidelines on vaccination and infectious diseases screening among refugees resettling in the U.S. is unknown. We sought to determine rates of vaccine completion and infectious diseases screening in refugees following resettlement.
Methods
We conducted a retrospective cohort study of refugees resettling in a region in the U.S. using medical data from June 2013–April 2015. We determined the proportion of vaccine-eligible refugees vaccinated with measles-mumps-rubella (MMR), hepatitis A/B, tetanus, diphtheria, and acellular pertussis (Tdap), and human papillomavirus (HPV) following resettlement. We also determined the proportion of refugees who completed HIV and hepatitis C (HCV) screening.
Results
One hundred and eleven subjects were included, primarily from Iraq (53%), Afghanistan (19%), and Eritrea (11%). Of the 84 subjects who were vaccine-eligible, 78 (93%) initiated and 42 (50%) completed vaccinations within one year of resettlement. Odds of completing vaccination were higher for men (OR: 2.38; 95%CI:1.02–5.71) and for subjects with English proficiency (OR: 3.70; 95%CI:1.04–17.49). Of the 78 subjects (70%) completing HIV screening, two (3%) were diagnosed with HIV. Nearly all subjects completed screening for HCV, and one had active infection.
Conclusion
While most refugees initiate vaccinations, only 50% completed vaccinations and 70% completed HIV screening within 1 year of resettlement. There is a need to emphasize vaccine completion and HIV screening in refugee patients following resettlement.
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Hall V, Banerjee E, Kenyon C, Strain A, Griffith J, Como-Sabetti K, et al. Measles outbreak — Minnesota April–may 2017. MMWR. 2017;66(27):713–7. https://doi.org/10.15585/mmwr.mm6627a1.
2. Lam E, McCarthy A, Brennan M. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations. Hum Vaccines Immunother. 2015;11(11):2627–36. https://doi.org/10.1080/21645515.2015.1096457.
3. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Global Migration and Quarantine. Guidance for evaluating and updating immunizations during the domestic medical examination for newly arrived refugees. 2021.
4. Chai SJ, Davies-Cole J, Cookson ST. Infectious disease burden and vaccination needs among asylees versus refugees, District of Columbia. Clin Infect Dis. 2013;56(5):652–8. https://doi.org/10.1093/cid/cis927.
5. Lee D, Weinberg M, Benoit S. Evaluation of measles-mumps-rubella vaccination among newly arrived refugees. Am J Public Health. 2017;107(5):684–6. https://doi.org/10.2105/AJPH.2017.303698.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献